Research Profile
The hospital has outstanding research capabilities and significant characteristics. In the past five
Visit of the Prof. Clay Johnston and Johnson & Johnson Delegation
On January 7, 2024, Professor Clay Johnston and a delegation from Johnson & Johnson visited the
CHANCE-3
Official TitleColchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Trans
PUMICE
Official TitleRecombinant Human Prourokinase（rhPro-UK）for Injection Versus Standard Medical Treatmen
TRACE-3
Official TitleA Phase 3, Multicenter, Prospective, Randomized, Open Label, Blinded-endpoint (PROBE)
DAISY
Official TitleA Phase II, Randomized, Double-blind, Placebo-controlled, Dose-Finding, Multi-center S
TASTE-2
Official TitleTreatment of Acute Ischemic STroke With Edaravone Dexborneol Ⅱ (TASTE-2)Brief SummaryT
INSURE
Official TitleINdobufen Versus aSpirin in acUte Ischemic stRokE（INSURE）Brief SummaryChina has the la
